Do Not Bank on a Bank Not Being a Person Under the Aia
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
BOZEMAN FINANCIAL LLC V. FEDERAL RESERVE BANK
Before Lourie, Dyk, and Moore. Appeal from the Patent Trial and Appeal Board.
Summary: Banks that are members of the Federal Reserve System but are operationally distinct from, and not owned by, the federal government are “persons” for purposes of the America Invents Act.
Several Federal Reserve banks (“the Banks”) petitioned for covered business method review of two of Bozeman’s patents. The Board found all of the claims of the challenged patents invalid under 35 U.S.C. § 101. Bozeman appealed the Board’s authority to decide the petitions by arguing the Banks are not “persons” under the AIA.
Bozeman argued the Banks are government entities, which the Supreme Court held in Return Mail are not “persons” under the AIA. Bozeman relied on the Banks being members of the U.S. Federal Reserve System, implementing policies of the United States, and conducting important governmental functions. The Federal Circuit disagreed and held the Banks are “persons” because they are not government-owned and are operationally distinct from the federal government. The Banks can also be sued for patent infringement in any court, whereas remedies against government entities are limited and must be filed in the Court of Federal Claims. Having concluded that the Board had the authority to resolve the petitions, the court affirmed the Board’s determination that the challenged claims are invalid under 35 U.S.C. § 101.
Editor: Paul Stewart
Written by: Ari Feinstein & Adam Powell
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…